Kerala AyurvedaBOM:530163 +1.59%55 Current Ratio is 0.47 as of Mar. 2026, which is 28% below its 10-year median of 0.65. GuruFocus rates BOM:530163 with a GF Score™ of 55/100 and a GF Value™ of ₹319.30 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,000 Drug Manufacturers companies, Kerala Ayurveda ranks worse than 94% on this metric.
The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Kerala Ayurveda's current ratio for the quarter that ended in Mar. 2026 was 0.47.
Kerala Ayurveda has a current ratio of 0.47. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If Kerala Ayurveda has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.
The historical rank and industry rank for Kerala Ayurveda's Current Ratio or its related term are showing as below:
BOM:530163'
s Current Ratio Range Over the Past 10 Years
Min: 0.44 Med: 0.65 Max: 1.08
Current: 0.47
During the past 13 years, Kerala Ayurveda's highest Current Ratio was 1.08. The lowest was 0.44. And the median was 0.65.
BOM:530163's Current Ratio is ranked worse than 94% of 1000
companies
in the Drug Manufacturers industry
Industry Median: 2
vs BOM:530163: 0.47
Kerala Ayurveda (BOM:530163) Current Ratio Explanation
The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.
Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.
The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.
If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.
Kerala Ayurveda Current Ratio Related Terms
Kerala Ayurveda Current Ratio Historical Data
* Premium members only.
The historical data trend for Kerala Ayurveda's Current Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Kerala Ayurveda's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kerala Ayurveda Current Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Kerala Ayurveda's Current Ratio distribution charts can be found below:
* The bar in red indicates where Kerala Ayurveda's Current Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kerala Ayurveda (BOM:530163) has a Current Ratio of 0.47 as of Mar. 2026. This is 28% below median its historical median of 0.65. Over the past decade, Kerala Ayurveda's Current Ratio has ranged from 0.44 to 1.08. According to the industry distribution chart, Kerala Ayurveda ranks #940 out of 1000 companies in the Drug Manufacturers industry, placing it in the top 94%.
Is Kerala Ayurveda's Current Ratio too high?
Kerala Ayurveda's current Current Ratio of 0.47 is 28% below median its 10-year median of 0.65. Over the past 10 years, this metric has ranged from a low of 0.44 to a high of 1.08. The Drug Manufacturers industry median Current Ratio is 2.00. Kerala Ayurveda's value of 0.47 is 76.5% below this industry median. Based on the distribution chart, Kerala Ayurveda ranks #940 out of 1000 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Kerala Ayurveda has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Kerala Ayurveda's Current Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Kerala Ayurveda ranks #940 out of 1000 companies for Current Ratio. This places Kerala Ayurveda in the lower half of its industry. The industry median Current Ratio is 2.00. Kerala Ayurveda's value of 0.47 is 76.5% below this benchmark. Historically, Kerala Ayurveda's own Current Ratio has ranged from 0.44 to 1.08 over the past decade. While the company's 10-year median is 0.65 vs. the industry median of 2.00, Kerala Ayurveda has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for a Drug Manufacturers company?
The median Current Ratio among Drug Manufacturers companies is 2.00, based on 1,000 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Kerala Ayurveda's current Current Ratio of 0.47 is 76.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Current Ratio is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Kerala Ayurveda's current Current Ratio is 0.47, which is 28% below median its own 10-year median of 0.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kerala Ayurveda stock overvalued right now?
Based on GuruFocus' analysis, Kerala Ayurveda (BOM:530163) is currently considered Possible Value Trap. The stock's GF Value™ is ₹319.30, compared to a current price of ₹165.75 — trading 48.1% below its estimated fair value. The current Current Ratio is 0.47, which is 28% below median its 10-year median of 0.65 and 76.5% below the Drug Manufacturers industry median of 2.00. Kerala Ayurveda's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Kerala Ayurveda (BOM:530163), the current Current Ratio is 0.47 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Kerala Ayurveda (BOM:530163) Overvalued in 2026?
Based on GuruFocus' analysis, Kerala Ayurveda stock appears to be undervalued.
The current stock price of ₹165.75 is trading 48.1% below its estimated GF Value™ of ₹319.30.
GuruFocus considers Kerala Ayurveda to be Possible Value Trap.
Key valuation signals for BOM:530163:
Current Ratio: 0.47 (28% below median its 10-year median of 0.65)
GF Value™: ₹319.30 vs. price of ₹165.75 (48.1% below fair value)
Industry Position: 76.5% below the Drug Manufacturers median (#940 of 1000)
No single metric tells the full story. See the BOM:530163 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Kerala Ayurveda Ltd is engaged in producing and selling ayurvedic products and providing healthcare services. The company offers ayurvedic medicine products for diabetes and heart health, skin and hair care, kids' health, women's care, men's care, gastro care, respiratory and allergy, general healthcare, massage oils, renal care, and joint care. It provides services through wellness clinics, resorts, hospitals, and academies. The company has only one reportable business segment, i.e., Full-spectrum Ayurvedic wellness. It generates maximum revenue from the sale of products. Geographically, the company generates maximum revenue from its business in India and also has some exposure to other markets.
55GF Score
Get the complete analysis for BOM:530163
Current Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530163 has been successfully added to your 
